An MS Drug Update

Cutting the risk for natalizumab-related PML, update on disability outcomes with ibudilast, and daclizumab pulled from the global market.

Source: Medscape Neurology Podcast - March 29, 2018 Category: Neurology Authors: Medscape Source Type: podcasts